Publications by authors named "Daniel A Arber"

Claim this Profile
A
Acute Leukemias of Ambiguous Lineage With RUNX1 Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With RUNX1 Mutations: A Study From the Bone Marrow Pathology Group.
Timothy J Kirtek, Weina Chen, Jaryse C Harris, Adam Bagg, Kathryn Foucar, Daniel A Arber

Am J Hematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study.
Irfan Yasin, Anna Stengel, Haipeng Shao, Amandeep Kaur, Emily F Mason, Daniel A Arber

Cancer· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early assessment of treatment response in AML using FLT PET/cT: a trial of the ECOG-ACRIN Cancer Research Group (EAI141).
Robert Jeraj, Fenghai Duan, Ryan J Mattison, Justin Romanoff, Lale Kostakoglu, Daniel A Arber

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guide to the diagnosis of lymphoid neoplasms in blood and bone marrow: A Bone Marrow Pathology Group approach.
Kathryn Foucar, Adam Bagg, Daniel A Arber, Carlos E Bueso-Ramos, Julia T Geyer

Am J Clin Pathol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Clinically Applicable Model Using Blood Counts to Support the Diagnosis of Prefibrotic Myelofibrosis Versus Essential Thrombocythemia.
Tiziano Barbui, Jürgen Thiele, Arianna Ghirardi, Hans Michael Kvasnicka, Umberto Gianelli, Daniel A Arber

Am J Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare composite of Rosai-Dorfman-Destombes disease and nodular lymphocyte-predominant B-cell (Hodgkin) lymphoma.
Madhavi Pandiri, Daniel A Arber

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Mastocytosis in 910 Patients: Prognostic Contribution of the International Consensus Classification in the Context of the Mayo Alliance Prognostic System.
Fnu Aperna, Maymona G Abdelmagid, Mahesh Kumar, Joseph H Butterfield, Thanai Pongdee, Daniel A Arber

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Karyotypic clonal fraction predicts adverse outcome in -mutated myeloid neoplasms: an International investigators Network (iTiN) study.
Madhavi Pandiri, Anna Stengel, Jingjing Zhang, Peng Wang, Haipeng Shao, Daniel A Arber

J Clin Pathol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults.
Ethan J Harris, Diren Arda Karaoglu, Madina Sukhanova, Yasmin Abaza, Theodoros Karantanos, Daniel A Arber

Blood Cancer J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Diagnostic Spectrum of Myelodysplastic Syndromes and Acute Myeloid Leukemia.
Daniel A Arber, Attilio Orazi

Adv Anat Pathol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations.
Mithun Vinod Shah, Kevin Hung, Anmol Baranwal, Monika M Kutyna, Aref Al-Kali, Daniel A Arber

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Approach to the Bone Marrow Workup and Diagnosis of Eosinophilia and Mast Cell Disorders.
Kaaren K Reichard, Tracy I George, Daniel A Arber

Adv Anat Pathol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Classification of Hematopoietic Neoplasms: The Why, How, and Who?
Daniel A Arber, James R Cook

Adv Anat Pathol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification of Myelodysplastic, Myeloproliferative, and Myelodysplastic/Myeloproliferative Neoplasms: The Past, Present, and Future.
Daniel A Arber, Attilio Orazi

Am J Hematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 -Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk-Stratification, and Management.
Mithun Vinod Shah, Daniel A Arber, Devendra K Hiwase

Am J Hematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multihit TP53 Mutations in Myeloproliferative Neoplasms and Acute Myeloid Leukemia: Comparative Analysis of Survival and Risk Factors in 142 Informative Cases.
Saubia Fathima, Maymona Abdelmagid, Ali Alsugair, Kebede H Begna, Aref Al-Kali, Daniel A Arber

Am J Hematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Validation of the International Consensus (ICC) Re-Classification of Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC) Into Genetic Subcategories.
Ayalew Tefferi, Daniel A Arber

Am J Hematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Classification of Hematopoietic Neoplasms: The Why, How, and Who? (Part l).
Daniel A Arber, James R Cook

Adv Anat Pathol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT.
Nicola Polverelli, Juan Carlos Hernández-Boluda, Francesco Onida, Carmelo Gurnari, Kavita Raj, Daniel A Arber

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort.
Mithun Vinod Shah, Kevin Hung, Anmol Baranwal, Gauri Wechalekar, Aref Al-Kali, Daniel A Arber

Blood Cancer J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 Mutations in Myeloproliferative Neoplasms: Context-Dependent Evaluation of Prognostic Relevance.
Ayalew Tefferi, Maymona Abdelmagid, Giuseppe G Loscocco, Saubia Fathima, Kebede H Begna, Daniel A Arber

Am J Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of WHO diagnostic criteria in "Classical Myeloproliferative Neoplasms" compared with the International Consensus Classification.
Jürgen Thiele, Hans Michael Kvasnicka, Umberto Gianelli, Daniel A Arber, Ayalew Tefferi

Blood Cancer J· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Leukemias of Ambiguous Lineage With MDS-Associated Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With MDS-Associated Mutations: A Study From the Bone Marrow Pathology Group.
Timothy J Kirtek, Weina Chen, Jaryse C Harris, Adam Bagg, Kathryn Foucar, Daniel A Arber

Am J Hematol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, immunophenotypic, and genomic findings of acute myeloid leukemia with RAM immunophenotype: Comparison with other CD56-positive acute leukemias.
Hanan Hamdan, Yen-Chun Liu, Sa A Wang, Jacob Bledsoe, Karen M Chisholm, Daniel A Arber

EJHaem· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What have we learned about TP53-mutated acute myeloid leukemia?
Moazzam Shahzad, Muhammad Kashif Amin, Naval G Daver, Mithun Vinod Shah, Devendra Hiwase, Daniel A Arber

Blood Cancer J· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis